Objective: The role of phosphorylation of the ryanodine receptor at serine-2808 (RyR S2808 ) in congestive heart failure (CHF) is controversial, and effects of RyR S2808 phosphorylation on contraction are unclear. It has been reported that diastolic sarcomere length (SL) fluctuations accompany propagating contractile waves due to propagating SR Ca 2+ release in trabeculae from rats with CHF. Here, we studied the influence of RyR destabilization by FK506 and isoproterenol on twitch force ( F tw ) and SL fluctuations in right ventricular (RV) trabeculae. We measured phosphorylation of RyR S2808 in rats with myocardial infarction (MI) with or without h-blockade and in rats during isoproterenol stimulation in order to assess the role of RyR S2808 phosphorylation in SL fluctuations in failing hearts. Methods: Five groups of male Lewis Brown -Norway rats were studied 3 months after MI: i) Sham; ii) MI with CHF (cMI); iii) MI without CHF; iv) metoprolol-treated MI, with and without CHF. The root mean square (RMS SL ) of SL fluctuations in RV trabeculae was calculated. Results: RMS SL increased strongly both following a short train of stimuli at 2.5 Hz and following catecholamine activation in trabeculae from MI with CHF, resulting in a decrease in F tw in proportion to RMS SL . RyR S2808 phosphorylation was increased significantly in the left ventricle (LV;¨58%, P < 0.05) but not in the RV (n.s.) in MI rats with CHF. FK506 tripled high frequency stimulation-induced RMS SL in nonfailing trabecula but did not further enhance RMS SL in failing trabecula. Isoproterenol increased RMS SL in nonfailing trabeculae only modestly despite a substantial increase in RyR S2808 phosphorylation in the RV (¨60%, P < 0.05). Isoproterenol induced SL fluctuation without an increase in RV-RyR S2808 phosphorylation in failing trabeculae. Chronic h-blockade decreased high frequency and catecholamine stimulation-induced RMS SL while RyR S2808 phosphorylation in the RV was indistinguishable from that in cMI. Conclusions: Acute RyR S2808 phosphorylation by itself does not cause spontaneous contractile waves owing to RyR2 destabilization. Spontaneous contractile waves in CHF are not caused by RyR S2808 phosphorylation alone, suggesting that factors other than RyR S2808 phosphorylation affect RyR function.
Introduction
Myocardial infarction (MI) leads to ventricular dilatation and dysfunction and ultimately to congestive heart failure (CHF). There is considerable evidence that failure of Ca occurs only in the form of Ca 2+ sparks without inducing microscopically visible contractile activity [1] . In contrast, noticeable fluctuations of diastolic sarcomere length (SL) accompany propagating contractile waves due to propagating SR Ca 2+ release in cells of trabeculae from rat with CHF [2, 3] . These SL fluctuations reduce force of the heartbeat and may cause arrhythmias [2] . The underlying spontaneous SR Ca 2+ release is dependent on the SR Ca 2+ content [4] and the threshold for opening of the RyR2 in response to SR luminal Ca 2+ [5] and contributes to a reduction in SR Ca 2+ content [6] , yet the influence of SL fluctuations on force of cardiac contraction is unclear. Activation of h 1 -adrenergic system persists in severe chronic CHF. CHF in dog and human heart is thought to be accompanied by increased phosphorylation of RyR2 by protein kinase A (PKA) causing FK506-binding protein (FKBP)12.6 to dissociate from RyR2, which increases the open probability of RyR2 [7] . It is well known that h-blockers are important tools in the treatment of chronic CHF and it has been reported that beneficial effect of h-blockers is related to normalized PKA phosphorylation of RyR2 at serine-2808 (rat-RyR S2808 , corresponding to rabbit-RyR S2809 ), and a decrease of spontaneous SR Ca 2+ release in severe CHF [8] . However, the question whether RyR S2808 is excessively phosphorylated in CHF is debated [8, 9] . In addition, the effect of increased phosphorylation of RyR S2808 (RyR S2808 phosphorylation) by PKA on dissociation of FKBP12.6 from RyR2 is controversial [7, 8, 10] , and it has been reported that RyR S2808 phosphorylation by itself does not change the RyR2 activity [11] .
In this study we hypothesize that the observed SR Ca 2+ leak [6] [7] [8] occurs in intact cardiac muscle in the form of spontaneous propagating Ca 2+ release accompanied by contractile waves which are reflected by SL fluctuations and reduce force of the next contraction [2] . Hence, we studied the effect of SL fluctuations on force development in RV trabeculae from rats after coronary artery ligation leading to MI with CHF (cMI) and without CHF (uMI). We explored the role of RyR2 destabilization, induced by the immunosuppressant FK506 (tacrolimus) and by isoproterenol, in SL fluctuations and force development in trabeculae. We measured RyR S2808 phosphorylation in uMI and cMI with or without h-blockade as well as during isoproterenol stimulation and assessed the role of RyR S2808 phosphorylation in SR Ca 2+ release in CHF.
Methods

Coronary artery ligation
MI was induced in male Lewis Brown -Norway, F1 rats (250 -320 g body weight; Harlan, Indianapolis, IN, USA) [2] . The rats were anesthetized with 40 mg/kg BW of sodium pentobarbital (i.p.), artificially ventilated and after left thoracotomy, the main left coronary artery was ligated using a 6 -0 nylon suture. Age-matched sham rats were prepared similarly without coronary artery ligation. The animals received analgesia for 48 hours using 2 mg/kg BW of Butorphanol Tartrate (Wyeth Animal health, Guelph, ON, Canada) (s.c.) and 50 mg/kg/day of Codeine Phosphate (Ratiopharm Inc., Canada) in their drinking water. The procedures were approved by the Animal Care Committee of the University of Calgary and complied with The Guide for the Care and Use of Laboratory Animals (NIH Publication no. 85-23, revised 1996) .
We have previously shown that MI rats with lung wet weight/body weight (LW/BW) > [(mean value of LW/BW in sham) + (2 S.D.)] exhibit signs of CHF [2] . The division according to LW/BW leaves no overlap between rats with CHF and those without CHF. Hence, we divided the rats into: MI rats with CHF (cMI) and those without evidence of CHF (uMI). MI rats treated with the h-blocker, metoprolol (hB), were divided into hB-cMI and hB-uMI.
Echocardiography
Animals were anesthetized with sodium pentobarbital (30 mg/kg BW; i.p.) and echocardiography (12-MHz transducer; Agilent SONOS 5500, Agilent Technologies, Andover, MA, USA) was performed 2, 6 weeks and 3 months after the surgery. Left ventricular (LV) end-diastolic dimension (LVEDD), LV end-diastolic area (LVEDA), and end-systolic area (LVESA) were measured at papillary muscle level. LVcontraction ([LVEDA À LVESA] / LVEDA Â 100%), was used as index of LV systolic function.
Diameter of the tricuspid valve annulus (TVD) was measured at aortic valve level in short axis view and used as an index of RV dilation (Fig. 1) . Transverse scar length was estimated by planimetric measurement of the LV endocardium that demonstrated a thinned wall and systolic akinesis in the LV short axis view. Animals were excluded after 2 weeks if the echocardiogram revealed a scar of < 40% of the LV circumference.
Central venous pressure ( P RA ) and RV systolic pressure ( P RV ) were measured using a polyethylene catheter (PE50) to estimate RV hemodynamics 3 months after surgery.
The time course of change in heart rate after isoproterenol (200 Ag/kg BW i.v.) was measured in control rats as well as the maximal response of heart rate and LVcontraction to isoproterenol (0.01, 0.1, 1, 10, 50, and 200 Ag./kg BW i.v.). The response of heart rate of cMI to isoproterenol (10 Ag/kg BW i.v.) was also measured.
b-blocker treatment
Twenty-eight rats were divided into 2 groups and monitored for 3 months. Group 1 received 1g/l metoprolol in their drinking water immediately after recovery from anesthesia. Group 2 received drinking water without metoprolol. There was no difference in water consumption between the groups. We chose 1 g/l metoprolol as the dose proved to inhibit the effect of isoproterenol on LVcontraction by 39% (23.6 T 4.9% in control (n = 5) vs. 14.5 T 1.0 in control with metoprolol (n = 5) 10 min after 1 Ag i.v./kg BW; P < 0.05).
RV trabeculae
Rats were sacrificed 3 months after surgery. Trabeculae from the RV were isolated and Scar, noninfarcted LV, RV and left atrium appendage were dissected and weighed. The scar area was determined by planimetry. The lungs were removed, blotted, and weighed immediately; then, the lungs were dried and weighed dry.
RV trabeculae were mounted in a perfused chamber on an inverted microscope as described previously [2] and stimulated (2 -2.5 ms pulses 1.5 Â threshold) at 0.5 Hz. The muscle chamber was perfused at 8 ml/min with a buffer solution with the following composition (in mmol/l): NaCl 137. Width of the trabeculae (in mm) was: 0.24 T 0.06, 0.24 T 0.10, 0.27 T 0.09, 0.30 T 0.10 and 0.33 T 0.14, in Sham, uMI, hB-uMI, hB-cMI, and cMI, respectively; thickness (in mm) was: 0.12 T 0.03, 0.11 T 0.02, 0.11 T 0.01, 0.14 T 0.04 and 0.18 T 0.05, in Sham, uMI, hB-uMI, hB-cMI and cMI, respectively. Trabeculae from cMI were thicker than from Sham and uMI but there was no significant difference between cMI and hB-cMI.
Force and SL measurements
Force was measured using a strain gauge (AE 801, Sensor One Technologies Corp, Sausalito, CA, USA). Twitch force ( F tw ) was normalized to cross-sectional area. F tw was measured at SL = 2.10 T 0.02 Am. SL was measured by laser diffraction as described previously [2, 12] . A region of the muscle with minimal translation during contraction was selected for SL measurement and was monitored using a CCD camera (SONY SSC-M370, SONY Co., Japan). The position of the median of the 1st order of the diffraction pattern was converted electronically to a voltage proportional to SL which was calibrated using test gratings. The resolution of SL in quiescent muscle was 2 nm [13] . F tw and SL were sampled at 1 kHz by a 12-bit A/D board (National Instruments Corporation, Austin, TX, USA).
Frequency potentiation
Stimulation at 2.5 Hz (30 stimuli) led to twitch potentiation ( F 1 , F 2 , etc.) upon return to stimulation at 0.5 Hz (Fig. 2) . F 1 after a 2.5-Hz train equaled maximal developed F tw ( F max ) at optimal [Ca 2+ ] o [12] ; hence, we measured Fmax using frequency potentiation. potentiated beats returned exponentially to the steady state, obeying:
where F n represents F tw of the nth contraction after frequency potentiation and F n+1 that of the subsequent beat ( Fig. 3A(a) ). D has been interpreted to reflect the fraction of Ca 2+ re-circulating to the SR [12] .
Analysis of diastolic SL fluctuations
We have described that SL fluctuations occur together with microscopically visible contractile waves (lasting¨300 ms and propagating at 100 Am/s) in cells of the trabeculae at elevated [Ca 2+ ] o from rats with CHF [2] . The waves caused multiple sub-peaks in the 1st order of the diffraction pattern, which were converted to fluctuations of the median of the SL distribution. We calculated the root mean square value of SL fluctuations (RMS SL ) around the average SL (SL mean ):
RMS SL (in nm) correlated with the incidence of contractile waves (i.e. 3 nm/(% of cells that generate waves/sec)) [2] .
When, in control experiments, the bath temperature was raised to 35 -C, F tw in cMI decreased as has been shown before (by 34% at 0.5 Hz [14] ) and RMS SL was at the detection limit of the system (1.3 nm). RMS SL increased substantially in cMI during the first twitches (0.5 Hz) after frequency potentiation at 35-C and significantly more than in uMI (6.97 T 3.54 nm (cMI n = 4) vs. 1.70 T 0.27 (uMI n = 3), P < 0.05). Raising [Ca 2+ ] o at 35 -C to 1.25 mmol/l also increased RMS SL substantially in cMI at 0.5 Hz but not in uMI (6.67 T 2.81 nm (cMI n = 4) vs. 1.83 T 0.12 (uMI n = 3), P < 0.05). These data show that the phenomenon of spontaneous contractile activity occurs both at body temperature and at 26.5 -C. Trabeculae are stable for a longer time at 26.5 -C; hence, we explored the effect of RyR2 destabilization, induced by FK506 and isoproterenol, on RMS SL at 26.5 -C. Furthermore, trabeculae from cMI are more sensitive [Ca 2+ ] o than normal trabeculae [2] and SL fluctuations lead to muscle deterioration [2, 13] ; hence we performed these studies at [Ca 2+ ] o = 0.4 mmol/l.
Effect of FK506 and isoproterenol on Ftw and SL fluctuations
After frequency potentiation, FK506 (5 Amol/l; generously provided by Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan) was added to 100 ml of circulating solution; F tw and RMS SL at 0.5 Hz and after frequency potentiation were measured 60 min later. We also measured the response of F tw and RMS SL in trabeculae at 0.5 Hz at 8-10 min after exposure of isoproterenol (100 nmol/l) using 35 rats. Finally, we tested the effects of isoproterenol on 4 hearts in vivo and on 4 hearts in vitro in a standard Langendorff setup.
Phosphorylation of RyR S2808
Phosphorylation of RyR S2808 was measured in triplicate in homogenates of the LV and RV from uMI and cMI, as well as in RV homogenates from in vivo rat hearts after i.v. injection of isoproterenol (1, 10, and 200 Ag/kg BW) and in Langendorff-perfused hearts exposed to isoproterenol (100 nmol/l; at [Ca 2+ ] o = 0.4 mmol/l) for 10 min. Furthermore, RyR S2808 phosphorylation was measured in RV homogenates from cMI at 6 min after i.v. injection of isoproterenol (10 Ag/kg BW).
The ventricles were crushed by an aluminum clamp precooled in liquid N 2 and stored at À80 -C. Frozen samples were pulverized in liquid N 2 and homogenized immediately (Brinkmann Polytron PT 15; setting 8; 4 Â 15 s) in 6 volumes of buffer ((in mmol/l): 30 KH 2 PO 4 (pH 7.0), 40 NaF, 5 EDTA, 300 sucrose, and protease inhibitors). Aliquots of homogenates were solubilized in 50 mmol/l Tris -HCl, pH 7.5, and 3% SDS for 1 h at room temperature, and insoluble materials were removed by centrifugation (16,000Âg for 10 min). Equal portions of the supernatant were subjected to 6% SDS -PAGE; then, the resolved proteins were transferred to nitrocellulose membranes in the presence of 0.01% SDS (45 V for 18 -20 h at 4 -C). The membranes were blocked with PBS containing 0.5% Tween-20 and 5% skim milk powder for 30 min. Two parallel membranes were loaded with equal amounts of protein. One membrane was, then, incubated for 3 hours at room temperature with anti-RyR2 antibody (1 : 1000; a polyclonal rabbit antibody kindly provided by Dr. Anthony Lai at Cardiff University, UK); the other membrane was incubated simultaneously with anti-S2808(PO 3 ) antibody (1 : 5000) [9, 10] .
Alternatively, a membrane was first probed with antiRyR2 antibody (1 : 1000) and, then, stripped of RyR2 antibody by incubation in a buffer containing 50 mM Tris -HCl, 2% SDS, and 0.1 M h-mercapto-ethanol (pH 6.8, 55 -C, 30 min). After the membrane had been washed with PBS (3Â; three times for 5 min each) and re-probed with the anti-S2808(PO3) antibody (1 : 5000), it was washed (15 min Â 3) with PBS containing 0.5% Tween-20 and incubated with secondary goat anti-rabbit IgG antibody conjugated to horseradish peroxidase (1 : 20,000; 30 min) and washed again.
RyR S2808 phosphorylation was determined by densitometry of luminescence of the Western blots and expressed as anti-serine-2808 luminescence/anti-RyR2 luminescence (S2808P/RyR2).
Statistics
Results are expressed as mean T S.D. Comparison between groups was performed by ANOVA followed by Scheffe's post hoc test or Student's unpaired t-test. Intragroup comparison was performed using Student's paired ttest. Linear regression analysis was used to describe the decay of F tw -potentiation. Differences were considered significant at P < .05.
Results
Echocardiography and pathology after coronary artery ligation
cMI was accompanied by a larger scar size and RV hypertrophy compared to uMI (Table 1) . RV weight in cMI was twice that of Sham, similar to previous reports [15] . Ventricular dilatation in cMI was echocardiographically significantly more severe than in uMI at 2 weeks and 3 months after surgery (LVEDD: 6.7 T 0.2, 9.7 T 0.6, and 11.5 T 0.4 mm in Sham, uMI, and cMI, respectively; LVEDA: 31.2 T 2.9, 71.9 T 7.3, and 95.1 T 9.4 mm 2 in Sham, uMI, and cMI, respectively). The RV was dilated (TVD > 5.0 mm) in all cMI. TVD correlated with systolic RV pressure in Sham, uMI and cMI (r 2 = 0.75, P < 0.0001, n = 14). Hence, we used TVD to diagnose CHF in MI rat in vivo (Fig. 1) . 
F tw and SL fluctuations in RV trabeculae in CHF
Trains of 30 stimuli at 2.5 Hz potentiated F tw after return to 0.5 Hz; the potentiated F tw decreased exponentially to the steady state F tw at 0.5 Hz in Sham trabeculae ( Fig. 2A) , giving rise to a linear relationship between the amplitude of subsequent contractions (Fig. 3A(a) slope = 0.83, r 2 = 0.999, P < 0.0001) [12, 16] . In contrast, the time-course of F tw after frequency potentiation in cMI trabeculae showed reduced force of the first twitches after return to 0.5 Hz. We calculated the apparent deficit in F tw ( F tw -deficit) as follows. First, we fitted the decay of force in 4th to 15th twitches after frequency potentiation by Eq. (1) when SL fluctuations had disappeared (slope = 0.80, r 2 = 0.999, P < 0.0001 in sham trabeculae; slope = 0.77, r 2 = 1, P < 0.0001 in cMI trabecula). Second, F tw -deficit was calculated from the difference between F tw predicted by Eq. (1) and measured F tw of the first three twitches after frequency potentiation. The F tw -deficit appeared proportional to RMS SL (slope = 1.9% measured F tw /nm, r 2 = 0.64, P < 0.0001, n = 148) in Sham, uMI, and cMI (Fig. 3B) .
F 0.5 Hz and F 0.5 Hz /F max and half relaxation time (RT50) were increased in cMI compared to sham and uMI (Fig. 4A) . Although RMS SL was small (|2 nm) in all groups at 0.5 Hz, RMS SL at 0.5 Hz after frequency potentiation in cMI increased significantly compared to other groups (Fig. 4B ).
Effects of FK-506 on F tw and SL fluctuations
FK506 (5 Amol/l) neither changed F tw nor increased RMS SL at a stimulus rate of 0.5 Hz. However, FK506 tripled RMS SL after 2.5 Hz stimulation and decreased potentiation of F tw in Sham and uMI (Table 2) . F tw -deficit was again proportional to RMS SL (slope = 2.8% measured F tw /nm, r 2 = 0.57, P < 0.0001 in sham (n = 32), slope = 4.3, r 2 = 0.75, P < 0.0001 in uMI (n = 36)). FK506 increased neither the already high RMS SL nor the deficit of F tw in cMI.
Effects isoproterenol on F tw , SL fluctuations, and cardiac muscle function
Isoproterenol (100 nmol/l) enhanced RMS SL three-fold in cMI trabeculae stimulated at 0.5 Hz, which contrasted a modest increase observed in all other groups (Fig. 5) . Furthermore, the substantial increase in F tw due to isoproterenol found in all other groups was absent in cMI, although isoproterenol accelerated relaxation in cMI in the same way as in the other groups.
Isoproterenol injection in vivo increased the heart rate to a maximum (16.2 T 3.9%) at 4 min after 200 Ag/kg BW i.v. followed by a decrease to near basal level in the next 30 min (17.8 T 4.2% at 10 min, and 4.2 T 0.6% at 30 min (Fig. 6) ). The responses of functional and biochemical cardiac parameters in vivo and in vitro were nearly identical (Fig. 7) . Heart rate and LV-contraction at 4 min increased with the isoproterenol dose and saturated at 10 Ag/kg BW (i.v.) (Fig. 7) . Maximum acceleration of the heart rate (16.8 T 3.0%) by isoproterenol (10 Ag /kg BW i.v., at 4 min, n = 3), in vivo, was similar to the steady state effect of isoproterenol (100 nmol/l for 10 min) on heart rate of spontaneously beating Langendorff perfused hearts (15.6 T 6.9%, n = 4). Importantly, isoproterenol (10 Ag/kg BW i.v., at 4 min) increased heart rate in cMI considerably less (36 T 14 bpm) than in control (69 T 12 bpm; P < 0.05).
Phosphorylation of RyR S2808
Baseline RyR S2808 phosphorylation (S2808P/RyR2) was substantial in the RV taken directly from the rat and similar to that in the RV from hearts that had been perfused with HEPES solution for 20 T 3 min. S2808P/RyR2 in the LV of cMI, but not of uMI, was increased compared to Sham ( P < 0.0004). S2808P/RyR2 in the RV of cMI was not significantly higher than in Sham ( P = 0.15; Fig. 8 ). Isoproterenol (10 Ag/kg BW i.v.), in vivo, increased S2808P/RyR2 substantially ( P < 0.003) in the RV of control hearts and as much as in the isolated heart (100 nmol/l for 10 min, P < 0.02; Fig. 7 ), but failed to increase S2808P/ RyR2 in the RV of cMI (1.06 T 0.043 (n = 3) vs. 1.00 T 0.089 in drug-free cMI (n = 4), P = 0.17).
Effects of chronic b-blockade
Metoprolol did not reduce LV size of cMI (LVEDA (in mm 2 ) 95.1 T 9.4 in cMI (n = 16) vs. 92.6 T 8.3 in hB-cMI (n = 9), P = 0.97) but clearly reduced RV size (TVD) and RV hypertrophy observed 3 months after surgery ( Fig. 1 and Table 1 ). Metoprolol also reduced RMS SL and F tw -deficit after frequency potentiation (Fig. 4) significantly, both in uMI and in cMI. Furthermore, chronic treatment with metoprolol reduced S2808P/RyR2 in the LV of cMI significantly compared to cMI ( P < 0.04; Fig. 8 RyR2 in the RV of cMI with metoprolol remained indistinguishable from Sham-operated animals.
Discussion
We show here that i) In RV trabeculae from rats, which exhibit all criteria of CHF (cMI), substantial SL fluctuations develop following increased frequency of stimulation and catecholamine activation, resulting in reduced F tw in proportion to RMS SL . ii) RyR S2808 phosphorylation was significantly increased in the LV but not in the RVof cMI. iii) FK506 increased RMS SL , induced by high frequency stimulation, 3-fold only in nonfailing trabeculae, but iv) isoproterenol at a saturating concentration increased RMS SL only modestly in nonfailing trabeculae in spite of a substantial increase in RyR S2808 phosphorylation in the RV ( P < 0.05). On the other hand: v) isoproterenol induces SL fluctuations in failing trabeculae without significant increase in RV RyR S2808 phosphorylation. vi) Chronic h-blockade ) and the response of S2808P/RyR2 from the RV from Langendorff hearts exposed to isoproterenol (100 nmol/l for 10 min). We converted the isoproterenol dose to the concentration of isoproterenol in the extracellular space in vitro ([ISO]) using the data from Ref. [22] . The data were fitted by a Hill function (solid line; EC 50 = 0.6 Ag/kg BW; Hill coefficient = 1; r 2 = 0.997, P < 0.0001). The EC 50 in vivo appeared to be nearly identical to the EC 50 of force response isolated trabeculae (vertical dashed line) [23] . (B) S2808P/RyR2 in control, after isoproterenol injections (1 and 10 Ag/kg BW; FISO-injection_) in vivo and after isoproterenol perfusion (100 nmol/l; FISO-perfusion_) in vitro. *Significant difference (unpaired t-test) compared to control. decreased SL fluctuations induced by high frequency stimulation and catecholamines in trabeculae of cMI while RyR S2808 phosphorylation in the RV remained indistinguishable from that in sham-operated animals and cMI.
F tw in RV trabeculae in CHF
Coronary artery ligation causing a scar in excess of 35% of the LV surface caused severe LV dilatation, pulmonary congestion, pulmonary hypertension, RV hypertrophy and RV dilation [2] . F 0.5 Hz increased and relaxation prolonged in RV trabeculae from the hearts of these cMI animals compared to uMI and Sham, probably due to an increase in [Ca 2+ ] i transient amplitude due to action potential prolongation [17] . These findings are consistent with those observed in severe pressure-induced RVH in a transitional stage to heart failure [18] .
SL fluctuations
We assume that microscopically visible propagating contractile waves, underlying SL fluctuations, reflect the response of sarcomeres to propagating waves of SR Ca 2+ release. This assumption is supported by: i) increase of [Ca 2+ ] i in the presence of SL fluctuations [13] and ii) their suppression by ryanodine [2, 19] . The assumption predicts that increased SR Ca 2+ load -such as due to high frequency stimulation [6] -will bring RyR2 closer to the threshold for spontaneous Ca 2+ release [5] and cause SL fluctuations. This happened in fact in cMI trabeculae, but not in uMI or Sham, suggesting that the threshold of the RyR2 for spontaneous Ca 2+ release is reduced in CHF. Excessive SL fluctuations were found in cMI at both 26.5 -C and 35 -C, showing that they reflect genuine properties of RV cardiac muscle in CHF.
Spontaneous SR Ca 2+ release, underlying SL fluctuations, is expected to render the SR temporarily unable to respond fully to an action potential. The latter would cause non-uniform Ca 2+ release and reduced force development by partially -along with fully activated -sarcomeres. Our data show that SL fluctuations (at RMS SL = 12 nm) indeed are accompanied by a substantially reduced twitch force (i.e. up to¨25% of maximal F tw ), and that this reduction is tightly coupled to the intensity of SL fluctuations immediately preceding the twitch.
Furthermore, recurrent spontaneous SR Ca 2+ release is expected to cause a chronic leak of Ca 2+ from the SR. We estimated the Ca 2+ leak from the SR owing to SL fluctuations in cMI (at RMS SL = 12 nm) to be¨5%/s of the SR Ca 2+ content [2] ); this value is similar both to the reported SR Ca 2+ leak in rabbit HF myocytes (7-10%/s; [6] ) and to Ca 2+ leak estimated from isolated canine cardiac SR vesicles in which FKBP12.6 dissociation had been induced by FK506 (¨2-4% of Ca 2+ -uptake into SR/s; [20] ). FK506 tripled stimulation-induced SL fluctuations and reduced potentiation of F tw in nonfailing (Sham and uMI) trabeculae, consistent with reports that FK506 dissociates FKBP12.6 from RyR and causes spontaneous SR Ca 2+ release [20, 21] . FK506 did not further increase stimulationinduced SL fluctuations in trabeculae from cMI, suggesting that the mechanism causing SL fluctuations in failing rat trabeculae was saturated. Taken together, these observations suggest that CHF induces instability of the RyR2 SR Ca 2+ release channels causing SL fluctuations that lead to reduced twitch force development.
Phosphorylation of serine-2808 -the effect of isoproterenol
Studies in failing dog heart and in explanted human failing heart have suggested that RyR S2808 phosphorylation is increased in CHF [7, 8] . In the present study, RyR S2808 phosphorylation increased significantly in the LV but not in the LV of uMI suggesting that LV RyR S2808 phosphorylation depends on the extent of ventricular remodeling. However, RyR S2808 phosphorylation was not increased in the RV of MI rats with CHF nor in uMI.
We studied the functional effects of adrenergic stimulation in RyR S2808 phosphorylation further by exposing intact anesthetized animals and both isolated heart and trabeculae to isoproterenol. In vivo i.v. injection of isoproterenol increased heart rate and LV contraction in a dose-dependent manner. Using the volume of distribution and half-life of isoproterenol in vivo (216 ml/kg BW and 4.2 min, respectively; [22] ), we converted the isoproterenol dose to the concentration of isoproterenol in the extracellular space ([isoproterenol]). The EC 50 of isoproterenol in vivo appeared to be near identical to the EC 50 of [isoproterenol] for force in trabeculae ( Fig. 7; [23] ). Furthermore the maximal increase of heart rate after isoproterenol in vivo was the same as that in Langendorff heart perfused with a saturating [isoproterenol] , while the maximal increase of LV contraction after isoproterenol in vivo was similar to that of force in trabeculae in vitro (Fig. 7) [23] . Fig. 7 also shows that RyR S2808 phosphorylation increases steeply with isoproterenol at a dose that is near the EC 50 for the functional parameters and shows that saturation occurs both in vivo and in vitro at 100 nmol/l. These data suggest that the cardiac response to isoproterenol in vivo and in vitro are similar and suggest that RyR S2808 phosphorylation contributes to the observed functional changes.
Isoproterenol accelerated relaxation and induced SL fluctuations in all groups. However, isoproterenol induced threefold larger SL fluctuations in cMI than in the other groups and, unlike uMI and Sham muscles, no increase of F tw was detected in cMI trabeculae. The modest increase of SL fluctuations induced by 100 nmol/l isoproterenol in nonfailing trabeculae is consistent with the report that increase of the amplitude of Ca 2+ sparks by PKA is due to increase in SR Ca 2+ content rather than destabilization of RyR2 [24] . This observation suggests that acute RyR S2808 phosphorylation does not destabilize RyR2 enough to induce spontaneous Ca 2+ waves, consistent with the assumption that complete RyR S2808 phosphorylation by PKA does not dissociate FKBP12.6 from normal RyR2 [9] .
The response to isoproterenol (10 Ag/kg BW i.v.) on heart rate in cMI in this study was substantially reduced compared to control, consistent with desensitization of the h 1 -adrenergic signaling pathway in cMI owing to chronic activation of h 1 -adrenergic system in CHF [25] . This dose of isoproterenol induced SL fluctuations without a significant increase in RyR S2808 phosphorylation in RV of cMI. Acceleration of Ca 2+ uptake stimulated by isoproterenol may explain this finding because the resultant increase of the SR Ca 2+ content may have exceeded the threshold for opening of the RyR2 in cMI. On the other hand, it cannot be ruled out that chronic CHF has altered a property of the SR Ca 2+ release channel in the RV other than by RyR S2808 phosphorylation such that it has become vulnerable to adrenergic drive. One possible -untested -alternative mechanism could be nitric oxide (NO) mediated; e.g. increased Snitrosylation of thiol-groups on RyR2 may have contributed to RyR2 destabilization and spontaneous SR Ca 2+ release [26] in CHF [27] .
The effects of chronic b-blockade
Chronic h-blockade suppressed the increase of RyR S2808 phosphorylation in the LV of cMI corroborating the assumption that RyR S2808 phosphorylation is mediated by chronic adrenergic effects on the heart in CHF. Chronic hblockade clearly reduced SL fluctuations induced by high frequency stimulation and exposure of isoproterenol. However, the lack of a significant increase of RyR S2808 phosphorylation in the RV suggests that other factors are involved in the development of SL fluctuations in CHF.
Conclusions
SL fluctuations are increased following stimulation at high stimulus rate and during catecholamine stimulation in CHF and are accompanied by a decrease in F tw in proportion to the degree of SL fluctuations measured by the RMS SL . Our data suggest that spontaneous SR Ca 2+ release causes the inability of failing cardiac muscle to increase its force in response to increased heart rate and sympathetic stimulation. These data also show that acute RyR S2808 phosphorylation by itself does not cause spontaneous SR Ca 2+ release owing to RyR2 destabilization. The lack of a significant increase of RyR S2808 phosphorylation in the RV in chronic CHF makes it unlikely that RyR2 destabilization is caused by RyR S2808 phosphorylation alone. Further studies are required to reveal the other factors that are involved in RyR2 destabilization in chronic CHF.
